ZURICH Novartis is exercising its option with ConatusPharmaceuticals for an exclusive license for the global development and commercialization of emricasan for treating liver disease NASH, the Swiss drugmaker said.
Debra Bright said she battled for years with mental illness and addiction to pain pills and other drugs that were all too easy to find where she lives in West Virginia, one of the states hardest hit by the country's opiate epidemic.
(Reuters Health) - Light, localized illnesses like a runny nose may not affect distance runners’ performance, but racing within days of an acute, systemic infection raises the odds of never finishing, researchers say.
Reuters is the news and media division of Thomson Reuters.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms.